<DOC>
	<DOCNO>NCT01372475</DOCNO>
	<brief_summary>Purpose : The purpose study demonstrate intra-articular injection new viscoelastic Hydrogel ( Hymovis ) superior Placebo ( phosphate buffer saline [ PBS ] subject symptomatic osteoarthritis knee .</brief_summary>
	<brief_title>Hymovis™ Versus Placebo Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female ambulant outpatient ≥ 40 year age active lifestyle : 2 . Has medical history OA symptom confirm least 3 month prior screen visit radiographic evidence OA , KellgrenLawrence grade 23 3 . Discontinuation analgesic/NSAID therapy prior baseline intent resume study 1 . Clinically significant apparent large effusion target knee ; 2 . Clinically significant valgus/varus deformity , ligamentous laxity meniscal instability assess Investigator ; 3 . Any musculoskeletal condition affect target knee would impair assessment effectiveness target knee Paget 's disease 4 . Medical history anaphylactic reaction 5 . History septic arthritis joint 6 . Females pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Hyaluronan</keyword>
	<keyword>Hyaluronic Acid</keyword>
	<keyword>Viscoelastic</keyword>
	<keyword>Hydrogel</keyword>
</DOC>